Pathophysiology of regression of synovial cysts of the lumbar spine: The ‘anti-inflammatory hypothesis’

• Published in: Medical hypotheses 2012-12, Vol.79 (6), p.813-818
• Main Authors: Mattei, Tobias A, Goulart, Carlos R, McCall, Todd D
• Format: Article
• Language: English
• Subjects: Cyclooxygenase 2 Inhibitors - therapeutic use; Cytokines - physiology; Humans; Inflammation - pathology; Internal Medicine; Lumbar Vertebrae - pathology; Magnetic Resonance Imaging; Male; Middle Aged; Models, Theoretical; Synovial Cyst - drug therapy; Synovial Cyst - pathology
• ISSN: 0306-9877; 1532-2777
• DOI: 10.1016/j.mehy.2012.08.034

Abstract The term ‘synovial cysts’ of the lumbar spine refers to cysts that arise from the zygapophyseal joint capsule of the lumbar spine. Although several cases of regression of lumbar spine synovial cysts after oral anti-inflammatory therapy as well as local steroid injection have already been reported in the literature, no study up to now has addressed the role of ‘inflammation suppression’ in the regression of such lesions. In fact most of the previous studies have regarded ‘spontaneous rupture’ as well as ‘instability resolution’ as the most probable explanations for such phenomenon. In this article the authors review the current experimental data about the role of cytokines and inflammation in the development of synovial cysts of the lumbar spine. Additionally with basis on both our clinical experience of regression of a synovial cyst after conservative treatment with a non-steroidal anti-inflammatory drug (Cox-2 inhibitor) as well as on the experimental data supporting the multi-factorial effects of such drugs on the lumbar facet joints, the authors hypothesize that inhibition of inflammation might play a significant role in the pathophysiology of lumbar spine synovial cysts’ regression.